CAMP4 THERAPEUTICS CORPORATION
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 14 | Q2 14 | Q3 14 | Q1 15 | Q3 15 | Q1 16 | Q2 16 | Q3 16 | Q1 17 | Q2 17 | Q3 17 | Q1 18 | Q2 18 | Q3 18 | Q1 19 | Q2 19 | Q3 19 | Q1 20 | Q2 20 | Q3 20 | Q1 21 | Q2 21 | Q3 21 | Q1 22 | Q2 22 | Q3 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 155.6 | 51.7 | 10.1 | 15.9 | 90.5 | 64.8 | 60.5 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.6 | 1.5 | 0.8 | 1.0 | 6.6 | 8.2 | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 62.1 | 21.1 | -1.9 | -3.0 | 59.3 | 39.7 | 40.0 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -45.4% | -63.3% | -152.6% | -78.8% | -9.4% | -10.3% | -11.3% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| – | – | 34.2% | 34.9% | – | – | – | 39.5% | 41.1% | 41.8% | 41.6% | 41.1% | 40.9% | 40.9% | 40.6% | 40.7% | 39.8% | 39.3% | 38.6% | 38.4% | 39.0% | 39.9% | 40.8% | 40.9% | 40.7% | 38.3% | 37.0% | 36.7% | 35.8% | 26.8% | 21.1% | -2.0% | -3.4% | -93.3% | 45.4% | 86.7% | 89.1% | 88.1% | 76.2% | 77.8% | |
| – | – | 8.9% | 9.2% | – | – | – | 3.6% | 0.7% | 2.1% | 2.2% | 1.5% | 2.9% | 2.3% | -0.6% | -1.7% | -4.0% | -7.0% | -7.0% | -11.5% | -11.3% | -8.6% | -9.1% | -6.2% | -7.8% | -8.8% | -6.8% | -4.4% | -8.8% | -14.6% | -32.9% | -95.1% | -98.0% | -8,142.2% | -3,530.6% | -1,785.1% | -1,402.4% | -1,488.3% | -1,322.6% | -1,242.5% | |
| – | – | 5.7% | 5.6% | – | – | – | 0.1% | -1.8% | 2.4% | 5.6% | 8.2% | 8.5% | 5.1% | -0.4% | -4.8% | -6.5% | -10.6% | -10.9% | -15.8% | -14.9% | -12.3% | -13.5% | -10.6% | -12.8% | -12.6% | -11.0% | -8.1% | -12.5% | -18.1% | -33.0% | -92.1% | -96.0% | -7,943.4% | -3,428.6% | -1,722.1% | -1,404.5% | -2,298.5% | -2,193.7% | -2,543.7% | |
| – | – | 7.1% | 11.1% | – | – | – | 6.6% | 6.5% | 11.3% | 14.4% | 22.3% | 20.0% | 16.0% | 7.8% | -0.2% | -1.7% | -3.1% | 1.3% | 3.5% | 3.7% | 4.9% | 0.0% | -9.0% | -12.1% | -14.7% | -11.0% | -5.4% | -5.1% | -11.4% | -26.5% | -80.7% | -86.7% | -7,055.7% | -3,272.2% | -1,534.8% | -1,254.0% | -852.8% | -667.2% | -681.2% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| – | – | 9.7% | 8.0% | – | – | – | 0.1% | -3.6% | 4.6% | 9.9% | 14.8% | 15.1% | 9.4% | -0.8% | -9.0% | -12.6% | -30.3% | -32.5% | -55.4% | -51.7% | -44.9% | -53.0% | -108.4% | -167.4% | -191.7% | -227.1% | -195.7% | -270.3% | – | -273.9% | – | – | -82.0% | -100.4% | -129.5% | -91.0% | -168.5% | -279.3% | – | |
| – | – | 7.1% | 3.8% | – | – | – | 0.1% | -1.5% | 1.9% | 4.2% | 6.1% | 5.2% | 3.1% | -0.2% | -2.6% | -4.3% | -7.9% | -8.0% | -12.4% | -11.8% | -9.7% | -10.6% | -8.3% | -9.8% | -9.2% | -8.5% | -6.5% | -7.8% | -67.0% | -137.5% | -166.0% | -241.1% | -66.1% | -82.5% | -101.0% | -61.8% | -68.2% | -81.8% | -114.8% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| -18 | -21 | -23 | -116 | -100 | -57 | -84 | -64 | -103 | -97 | -106 | -139 | -241 | -235 | -67 | -70 | -64 | -99 | -96 | -81 | -92 | -98 | -83 | -52 | -46 | -39 | -36 | -30 | -34 | -34 | -9.2 | -9.5 | 0.6 | -61 | -46 | -36 | -72 | -109 | -99 | -86 | |
| – | – | -0.8 | -3.7 | – | – | – | -2.0 | -4.1 | -3.2 | -3.4 | -4.5 | -6.7 | -6.9 | -2.8 | -3.1 | -3.5 | -6.8 | -5.8 | -5.4 | -12.1 | -28.1 | -77.9 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 74.3% | 75.5% | 72.4% | 48.2% | 49.1% | 44.4% | 43.1% | 41.8% | 40.8% | 41.8% | 42.3% | 41.0% | 34.3% | 33.1% | 30.6% | 29.3% | 33.9% | 26.1% | 24.7% | 22.5% | 22.8% | 21.5% | 19.9% | 7.6% | 5.9% | 4.8% | 3.8% | 3.3% | 2.9% | -225.2% | 50.2% | -491.3% | -744.1% | 80.6% | 82.2% | 78.0% | 67.9% | 40.5% | 29.3% | -0.7% | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.0 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.6 | 0.6 | 0.2 | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | 0.1 | 0.3 | 0.1 | 0.3 | 0.4 | 0.4 | 0.5 | – | 0.2 | – | – | 0.0 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | – | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| – | – | 0.38 | 0.38 | – | – | – | 0.01 | -0.18 | 0.24 | 0.55 | 0.82 | 0.91 | 0.55 | -0.05 | -0.52 | -0.71 | -1.11 | -1.13 | -1.59 | -1.42 | -1.15 | -1.20 | -0.87 | -1.01 | -0.99 | -0.90 | -0.66 | -0.77 | -1.89 | -3.40 | -2.55 | -2.64 | -2.66 | -2.65 | -2.57 | -2.65 | -1.55 | -1.49 | -1.85 | |
| – | – | 6.72 | 6.75 | – | – | – | 9.51 | 10.07 | 9.76 | 9.79 | 10.05 | 10.74 | 10.80 | 11.04 | 10.93 | 10.86 | 10.55 | 10.32 | 10.07 | 9.51 | 9.39 | 8.89 | 8.18 | 7.92 | 7.91 | 8.16 | 8.22 | 6.18 | 10.43 | 10.30 | 2.77 | 2.75 | 0.03 | 0.08 | 0.15 | 0.19 | 0.07 | 0.07 | 0.07 | |
| 3.74 | 3.75 | 3.93 | 4.73 | 4.94 | 5.15 | 4.92 | 4.72 | 4.97 | 5.17 | 5.55 | 5.55 | 6.02 | 5.83 | 5.96 | 5.76 | 5.64 | 3.68 | 3.47 | 2.87 | 2.75 | 2.57 | 2.26 | 0.80 | 0.61 | 0.52 | 0.40 | 0.34 | 0.29 | -6.34 | 1.24 | -7.54 | -8.15 | 3.24 | 2.64 | 1.98 | 2.91 | 0.92 | 0.53 | -0.01 | |
| – | – | 0.48 | 0.75 | – | – | – | 0.62 | 0.65 | 1.10 | 1.41 | 2.24 | 2.15 | 1.73 | 0.86 | -0.02 | -0.18 | -0.33 | 0.13 | 0.35 | 0.35 | 0.46 | 0.00 | -0.73 | -0.96 | -1.17 | -0.90 | -0.44 | -0.31 | -1.18 | -2.72 | -2.23 | -2.38 | -2.36 | -2.53 | -2.29 | -2.36 | -0.57 | -0.45 | -0.50 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.